Medication Overuse Headache: How to Break the Cycle

Medication overuse headache (MOH) — sometimes called rebound headache — is one of the most common and most treatable causes of chronic daily headache. It develops when people use acute pain medication too frequently: opioids or combination analgesics on 10 or more days per month, or triptans and NSAIDs on 15 or more days per month. The only way to break the cycle is to stop the overused medication, which causes a temporary worsening before improvement arrives.

This guide draws on peer-reviewed research from three headache specialists in the Convene directory: Richard Lipton, MD, at Montefiore Medical Center, whose landmark population studies documented how episodic migraine progresses to chronic migraine under medication overuse [1][2][3]; Charles Argoff, MD, at Albany Medical Center, who contributed to the American Academy of Neurology guidelines on preventive migraine treatment [4][5]; and Peter Goadsby, MD, at UCLA, whose work on headache classification and treatment frameworks helped define how the field diagnoses and manages this condition [6][7].

Who gets medication overuse headache

The International Classification of Headache Disorders defines MOH as headache occurring on 15 or more days per month in a patient who has been overusing one or more acute medications for at least three months [6]. Nearly everyone who develops MOH has an underlying primary headache disorder, most commonly migraine. People without migraine who take pain medications just as often generally do not develop MOH, which tells us something important: the underlying brain biology of migraine makes certain patients vulnerable in a way others are not.

The numbers are larger than most people realize. Lipton and colleagues found that roughly 3% of adults in the United States have chronic migraine, defined as 15 or more headache days per month, and MOH is estimated to be a contributing factor in a substantial fraction of those cases [1]. Globally, MOH is among the ten most disabling conditions when measured by years lived with disability. Most patients with MOH were trying to manage their migraines responsibly. They reached for a pill because they had a bad headache, which is a completely reasonable thing to do. The problem is that doing it too often changes how the brain responds to pain.

Why frequent medication use worsens headache

The biology behind MOH is not addiction, and it is worth being clear about that. What happens is a neurological change in how the brain modulates pain. Frequent use of acute headache medications leads to sensitization of the trigeminal pain pathways — the same pathways that generate migraine — and disrupts the descending systems that normally suppress pain signals. The brain, in effect, recalibrates toward a lower threshold for headache. Once that recalibration happens, the absence of the medication itself triggers headache, which drives the patient to take more medication, which deepens the sensitization.

Not all medications carry the same risk. A 2008 longitudinal population study by Lipton and colleagues followed people with episodic migraine over time and found that opioids and butalbital-containing combination analgesics were the strongest drivers of progression from episodic to chronic migraine — more so than triptans or simple NSAIDs [3]. This does not mean triptans are risk-free at high frequency, but it does mean the choice of rescue medication matters. Triptans, which act specifically on serotonin receptors involved in migraine, carry lower transformation risk than opioids, which act on broadly distributed pain receptors and have stronger effects on the central pain modulation systems [2].

The at-risk thresholds to know

The specific cutoffs that define dangerous overuse come from the ICHD diagnostic criteria [6]:

• Opioids, butalbital, and combination analgesics (products containing caffeine plus aspirin or acetaminophen): 10 or more treatment days per month
• Triptans, ergotamines, NSAIDs, and acetaminophen used alone: 15 or more treatment days per month

These thresholds apply over a period of at least three months. Using ibuprofen 16 days in one bad month does not create MOH. The pattern has to be sustained. The most practical tool for knowing where you stand is a headache diary. Recording the date, duration, severity, and medication taken for each headache day takes about thirty seconds per entry and makes it possible to see your pattern clearly — something that is very difficult to do from memory alone.

Step-by-step: how to stop MOH

Breaking the cycle requires stopping the overused medication. There is no other way. The steps below are how most headache specialists approach it.

Step 1: Commit to detox with your neurologist. Trying to stop on your own is possible but harder and less successful. A neurologist can confirm the diagnosis, explain what to expect, and put a bridging plan in place. Do not attempt to stop opioids without medical supervision.

Step 2: Choose abrupt or gradual withdrawal based on the medication. For triptans and NSAIDs, abrupt discontinuation is usually recommended — it tends to result in a shorter and more predictable withdrawal period. For opioids and barbiturates (butalbital), gradual tapering is standard practice because abrupt cessation carries risks including withdrawal seizures at high doses. Your neurologist will set the taper schedule.

Step 3: Expect a withdrawal period. Almost everyone gets worse before they get better. The withdrawal headache typically peaks in the first two to five days and resolves within two to ten days for most patients stopping triptans or NSAIDs. Opioid withdrawal can take longer. Knowing this window in advance is important: the worsening is not a sign of failure, it is the expected course of the brain resetting its pain threshold.

Step 4: Use bridging therapy to manage withdrawal symptoms. A short course of oral corticosteroids (prednisone or dexamethasone) can reduce the severity and duration of withdrawal headache. Intravenous dihydroergotamine (DHE) administered in an infusion center or inpatient setting is an option for more severe cases. Naproxen, used as a temporary bridge during triptan or opioid withdrawal (not as the drug being withdrawn), can also help. Antiemetics like metoclopramide or ondansetron address the nausea that often accompanies withdrawal.

Step 5: Start preventive therapy. Stopping the overused medication without starting a preventive is like turning off a leak without fixing the pipe. Most patients who successfully detox need a preventive medication to keep their underlying migraine frequency low enough that they never need rescue medication on enough days to re-trigger MOH.

Preventive medications that work

The 2012 AAN guideline update on pharmacologic treatment for episodic migraine prevention, co-authored by Argoff and Lipton, identifies the medications with the strongest evidence [4]. Level A evidence (established efficacy, highest tier) supports topiramate, valproate, propranolol, and metoprolol. Level B evidence supports amitriptyline. These are the first-line options most neurologists consider.

More recently, the CGRP monoclonal antibodies (erenumab, fremanezumab, galcanezumab, eptinezumab) have shown efficacy specifically in patients with chronic migraine who have MOH — a population that was often excluded from earlier trials. These drugs do not require daily pill-taking, which removes one compliance barrier, and their side effect profile is gentler than topiramate or valproate for most patients. They are not universally covered by insurance without a prior authorization, but they are increasingly part of the toolkit for MOH patients who have not responded to first-line preventives.

The AAN also identified evidence supporting non-pharmacologic options including certain NSAIDs for prevention, which Argoff and colleagues reviewed in a companion guideline on complementary preventive treatments [5]. Magnesium, riboflavin, and butterbur extract have lower-level but positive evidence and are sometimes used alongside prescription preventives.

What withdrawal feels like and what helps

The withdrawal period is the reason many patients fail on their first attempt without professional support. In the first few days, headaches typically worsen and are accompanied by nausea, anxiety, irritability, difficulty sleeping, and sometimes sweating or restlessness. These symptoms are genuine, and they are temporary.

Staying well hydrated matters. Rest matters. For patients withdrawing from triptans or NSAIDs (not from the medication being used as a bridge), naproxen can reduce withdrawal severity. Antiemetics help with nausea. Some patients find that a three- to five-day course of oral prednisone at doses around 60 mg tapered down makes withdrawal headache manageable without needing hospitalization.

Inpatient or day-hospital detox is reserved for patients with severe opioid or barbiturate dependence, those who have failed two or more outpatient withdrawal attempts, or those with significant psychiatric comorbidity. The evidence for inpatient protocols using IV DHE, first described for intractable migraine, shows high rates of headache improvement in MOH patients treated in that setting.

After withdrawal: preventing relapse

Roughly one in four patients who successfully withdraw from overused medications will relapse within a year. Prevention depends on three things: accurate tracking, strict limits, and an effective preventive regimen.

Keep a headache diary indefinitely. Seeing the number of medication days per month in writing is the clearest early warning system for creeping overuse. Set a personal limit — for most patients this means treating no more than two days per week and no more than nine days per month — and treat that limit as firm rather than flexible.

Take preventive medication consistently. The most common reason MOH recurs is that patients stop their preventive when they feel better, which removes the protection that was keeping their underlying migraine frequency low. Lifestyle factors that reliably influence headache frequency include sleep regularity, stress management, consistent caffeine intake (not too much, not abrupt drops), and regular meals. These are not cures, but they lower the baseline load on a nervous system that is already prone to migraine.

Questions to ask your neurologist

• Which of my medications, and at what frequency, are putting me at risk for MOH — or do I already meet the criteria?
• Should I stop my rescue medications abruptly, or do I need a taper? Do I need any bridging therapy to get through withdrawal?
• What preventive medication do you recommend for my migraine pattern, and what are the realistic expectations for how much it will reduce my headache days?
• How will I know whether withdrawal is succeeding versus whether something else is wrong? What symptoms should prompt me to call you during detox?
• After I get through withdrawal, what strict limits should I set on rescue medication use, and what is the plan if I find myself exceeding them again?

The bottom line

Medication overuse headache is a neurological condition, not a character flaw, and it is reversible. The path out requires stopping the overused medication — which means tolerating a short but difficult withdrawal window — and replacing it with a preventive strategy that reduces how often headaches occur in the first place. Most patients who complete supervised withdrawal with an adequate preventive plan in place see a substantial reduction in their headache frequency within weeks to months. The sooner the cycle is identified and addressed, the easier it is to break.